Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03515083 · ClinicalTrials.gov registry record · NA
Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm
A NA study, sponsored by Saint Luke's Health System.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03515083: Completed NA study, sponsored by Saint Luke's Health System.
NCT03515083 is a NA study that has completed, run by Saint Luke's Health System. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03515083, a NA study, has completed, sponsored by Saint Luke's Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
There is a need to determine actual compliance of direct oral anticoagulants and how to improve this to reduce risk of stroke in patients with atrial fibrillation. Mobile health tools have been implemented world-wide in various patient populations as means of reducing cardiovascular risk and improving disease management. Results of these interventions have been mixed with some interventions demonstrating significant improvement while others demonstrated no difference between the intervention group and the control group. More importantly, these studies indicate that implementation of mobile health tools is feasible in various patient populations and it may just be a matter of finding the correct intervention for a given disease state. The aim of this study is to increase awareness of atrial fibrillation as a means of improving compliance with anticoagulant medication.
Primary Outcome
percent compliance with apixaban therapy
Interventions
- DEVICE Alive Cor Kardia mobile electrocardiogram monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-07-17 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
What the finished NCT03515083 record still lists
NCT03515083 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Alive Cor Kardia mobile electrocardiogram monitor is the first listed.
NCT03515083 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03515083 about?
NCT03515083 is a clinical study titled "Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm". There is a need to determine actual compliance of direct oral anticoagulants and how to improve this to reduce risk of stroke in patients with atrial fibrillation. Mobile health tools have been implemented world-wide in various patient populations as means of reducing cardiovascular risk and improvi...
What is the current status of trial NCT03515083?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2017-07-17. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT03515083?
The interventions under investigation include: Alive Cor Kardia mobile electrocardiogram monitor (DEVICE).
Who is sponsoring clinical trial NCT03515083?
This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03515083's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI